| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $47.3M | +5.3% |
| SG&A Expense | $15.4M | +36.3% |
| Operating Income | -$62.7M | -11.5% |
| Interest Expense | $1.7M | -2.8% |
| Income Tax | $0 | — |
| Net Income | -$62.0M | -7.4% |
| EPS (Basic) | -$1.06 | +0.9% |
| EPS (Diluted) | -$1.06 | +0.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $144.4M | -37.2% |
| Short-term Investments | $29.9M | — |
| Current Assets | $181.0M | -22.2% |
| Total Assets | $181.3M | -22.2% |
| Current Liabilities | $15.4M | +30.5% |
| Long-term Debt | $16.3M | +1.8% |
| Total Liabilities | $30.3M | +10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.6M | -33.1% |
| Capital Expenditures | $16K | +109.0% |
| Investing Cash Flow | -$30.0M | — |
| Financing Cash Flow | $1.2M | -99.4% |
| Free Cash Flow | -$56.7M | -33.1% |
| Stockholders' Equity |
| $151.0M |
| -26.6% |